Myasthenia gravis trials in India

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  Where

  Bangalore, Hyderabad, Mangalore, Nashik, Pune

  Age

  18 years and over

  People

  264 worldwide

  Run by

  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany

  See details and how to joinNCT06463587 · EU 2023-507746-83-00